Soros buys Okta, cuts Amazon in Q1
PremiumThe FlySoros buys Okta, cuts Amazon in Q1
6M ago
CERE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CERE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
Cerevel Therapeutics’ tavapadon meets Phase 3 primary endpoint in Parkinson’s
Premium
The Fly
Cerevel Therapeutics’ tavapadon meets Phase 3 primary endpoint in Parkinson’s
7M ago
Neumora Therapeutics appoints Panandiker as Chief Commercial Officer
PremiumThe FlyNeumora Therapeutics appoints Panandiker as Chief Commercial Officer
10M ago
Cerevel Therapeutics price target raised to $45 from $25 at JPMorgan
Premium
The Fly
Cerevel Therapeutics price target raised to $45 from $25 at JPMorgan
10M ago
Karuna downgraded, Arm target raised: Wall Street’s top analyst calls
Premium
The Fly
Karuna downgraded, Arm target raised: Wall Street’s top analyst calls
10M ago
Cerevel Therapeutics downgraded to Hold from Buy at Stifel
PremiumThe FlyCerevel Therapeutics downgraded to Hold from Buy at Stifel
11M ago
The biopharma stocks to own in 2024, according to Morgan Stanley
Premium
The Fly
The biopharma stocks to own in 2024, according to Morgan Stanley
11M ago
The biopharma stocks to own in 2024, according to Morgan Stanley
Premium
The Fly
The biopharma stocks to own in 2024, according to Morgan Stanley
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100